Literature DB >> 7499009

Visceral leishmaniasis during pregnancy treated with meglumine antimoniate.

R Utili1, A Rambaldi, M F Tripodi, A Andreana.   

Abstract

Data on the efficacy and safety of pentavalent antimony in the treatment of visceral leishmaniasis during pregnancy are scanty. A case of visceral leishmaniasis in a 39-year-old woman in the second trimester of pregnancy is reported here. The patient was hospitalized in poor condition with high fever and pancytopenia which had lasted for 6 weeks. A bone marrow aspirate revealed numerous amastigotes and serodiagnosis for Leishmania was positive at a high titer. The patient was successfully treated with meglumine antimoniate at a daily dose of 850 mg of antimony for 20 days. She delivered at term a healthy female baby who remains in good condition at 18 months of age. Thus a dose of 850 mg of antimony, which is lower than that presently recommended, seems to be effective and non toxic to the fetus when administered at the second trimester of pregnancy.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7499009     DOI: 10.1007/bf01793862

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  8 in total

1.  Practical progress and new drugs for changing patterns of leishmaniasis.

Authors:  P L Olliaro; A D Bryceson
Journal:  Parasitol Today       Date:  1993-09

2.  Leishmaniasis acquired in Belgium.

Authors:  G Kaplanski; C Farnarier; J M Durand; J Soubeyrand; P Bongrand; S Kaplanski
Journal:  Lancet       Date:  1991-10-05       Impact factor: 79.321

3.  Congenital kala-azar.

Authors:  T P Yadav; H Gupta; U Satteya; R Kumar; V Mittal
Journal:  Ann Trop Med Parasitol       Date:  1989-10

4.  [Kala-azar in pregnant women].

Authors:  P Massip; C Goutner; Y Dupic; P Navarrot
Journal:  Presse Med       Date:  1986-05-17       Impact factor: 1.228

5.  Congenital visceral leishmaniasis: case report.

Authors:  P M Nyakundi; R Muigai; J B Were; C N Oster; G S Gachihi; G Kirigi
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

Review 6.  Antiparasitic agents.

Authors:  J E Rosenblatt
Journal:  Mayo Clin Proc       Date:  1992-03       Impact factor: 7.616

7.  Congenital kala-azar and leishmaniasis in the placenta.

Authors:  I A Eltoum; E E Zijlstra; M S Ali; H W Ghalib; M M Satti; B Eltoum; A M el-Hassan
Journal:  Am J Trop Med Hyg       Date:  1992-01       Impact factor: 2.345

Review 8.  Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy, and future strategies.

Authors:  J D Berman
Journal:  Rev Infect Dis       Date:  1988 May-Jun
  8 in total
  1 in total

Review 1.  Visceral leishmaniasis (kala-azar) and pregnancy.

Authors:  Ernesto Antonio Figueiró-Filho; Geraldo Duarte; Patrícia El-Beitune; Silvana Maria Quintana; Tamara Lemos Maia
Journal:  Infect Dis Obstet Gynecol       Date:  2004
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.